Microbix Financial Statements From 2010 to 2025
| MBXBF Stock | USD 0.16 0.00 0.00% |
Check Microbix Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbix Biosystems' main balance sheet or income statement drivers, such as , as well as many indicators such as . Microbix financial statements analysis is a perfect complement when working with Microbix Biosystems Valuation or Volatility modules.
Microbix |
Microbix Biosystems OTC Stock Return On Asset Analysis
Microbix Biosystems' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Microbix Biosystems Return On Asset | 0.0056 |
Most of Microbix Biosystems' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microbix Biosystems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Microbix Biosystems has a Return On Asset of 0.0056. This is 100.06% lower than that of the Biotechnology sector and 100.02% lower than that of the Health Care industry. The return on asset for all United States stocks is 104.0% lower than that of the firm.
Microbix Biosystems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Microbix Biosystems's current stock value. Our valuation model uses many indicators to compare Microbix Biosystems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Microbix Biosystems competition to find correlations between indicators driving Microbix Biosystems's intrinsic value. More Info.Microbix Biosystems is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Microbix Biosystems' earnings, one of the primary drivers of an investment's value.About Microbix Biosystems Financial Statements
Microbix Biosystems stakeholders use historical fundamental indicators, such as Microbix Biosystems' revenue or net income, to determine how well the company is positioned to perform in the future. Although Microbix Biosystems investors may analyze each financial statement separately, they are all interrelated. For example, changes in Microbix Biosystems' assets and liabilities are reflected in the revenues and expenses on Microbix Biosystems' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Microbix Biosystems. Please read more on our technical analysis and fundamental analysis pages.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada. MICROBIX BIOSYSTEMS operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 100 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Microbix OTC Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.